Ladostigil Reduces the Adenoside Triphosphate/Lipopolysaccharide-Induced Secretion of Pro-Inflammatory Cytokines from Microglia and Modulate-Immune Regulators, TNFAIP3, and EGR1

Fanny Reichert,Keren Zohar,Elyad Lezmi,Tsiona Eliyahu,Shlomo Rotshenker,Michal Linial,Marta Weinstock
DOI: https://doi.org/10.3390/biom14010112
IF: 6.064
2024-01-17
Biomolecules
Abstract:Treatment of aging rats for 6 months with ladostigil (1 mg/kg/day) prevented a decline in recognition and spatial memory and suppressed the overexpression of gene-encoding pro-inflammatory cytokines, TNFα, IL1β, and IL6 in the brain and microglial cultures. Primary cultures of mouse microglia stimulated by lipopolysaccharides (LPS, 0.75 μg/mL) and benzoyl ATPs (BzATP) were used to determine the concentration of ladostigil that reduces the secretion of these cytokine proteins. Ladostigil (1 × 10−11 M), a concentration compatible with the blood of aging rats in, prevented memory decline and reduced secretion of IL1β and IL6 by ≈50%. RNA sequencing analysis showed that BzATP/LPS upregulated 25 genes, including early-growth response protein 1, (Egr1) which increased in the brain of subjects with neurodegenerative diseases. Ladostigil significantly decreased Egr1 gene expression and levels of the protein in the nucleus and increased TNF alpha-induced protein 3 (TNFaIP3), which suppresses cytokine release, in the microglial cytoplasm. Restoration of the aberrant signaling of these proteins in ATP/LPS-activated microglia in vivo might explain the prevention by ladostigil of the morphological and inflammatory changes in the brain of aging rats.
biochemistry & molecular biology
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to explore how ladostigil reduces the secretion of pro - inflammatory cytokines in microglia induced by adenosine triphosphate (ATP) and lipopolysaccharide (LPS), and regulates the expression of immune - regulatory genes TNFAIP3 and EGR1. Specifically, the research aims to: 1. **Determine the effective concentration of ladostigil**: Through experiments, determine at what concentration ladostigil can effectively inhibit the secretion of IL1β, IL6 and TNFα in microglia activated by BzATP and LPS. 2. **Verify the in - vivo drug concentration**: Measure the ladostigil concentration in the blood of aged rats treated with ladostigil to confirm whether it is sufficient to affect the release of cytokines in microglia. 3. **Explore the mechanism of action of ladostigil**: Use RNA sequencing technology to analyze in detail the effect of ladostigil on microglia gene expression, with particular attention to the expression changes of TNFAIP3 and EGR1. These research objectives aim to gain an in - depth understanding of the potential mechanisms of ladostigil in suppressing the inflammatory response and improving cognitive function in aged rats.